000			01927 a2200553 4500
005			20250515035448.0
264		0	_c20070312
008			200703s 0 0 eng d
022			_a0340-7004
024	7		_a10.1007/s00262-006-0195-x _2doi
040			_aNLM _beng _cNLM
100	1		_aTang, Yan
245	0	0	_aAn altered peptide ligand for naïve cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity. _h[electronic resource]
260			_bCancer immunology, immunotherapy : CII _cMar 2007
300			_a319-29 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAmino Acid Substitution _ximmunology
650	0	4	_aAnimals
650	0	4	_aBinding Sites
650	0	4	_aBinding, Competitive
650	0	4	_aBrefeldin A _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aDendritic Cells
650	0	4	_aDose-Response Relationship, Immunologic
650	0	4	_aEpitopes, T-Lymphocyte _xdrug effects
650	0	4	_aHLA-A Antigens _xdrug effects
650	0	4	_aHLA-A2 Antigen
650	0	4	_aHumans
650	0	4	_aInterferon-gamma _xbiosynthesis
650	0	4	_aIntramolecular Oxidoreductases _ximmunology
650	0	4	_aLeukocytes, Mononuclear _ximmunology
650	0	4	_aLigands
650	0	4	_aMembrane Proteins _xchemistry
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aModels, Molecular
650	0	4	_aPeptide Fragments _xchemistry
650	0	4	_aReference Values
650	0	4	_aStructure-Activity Relationship
650	0	4	_aT-Lymphocytes, Cytotoxic _xdrug effects
700	1		_aLin, Zhihua
700	1		_aNi, Bing
700	1		_aWei, Jing
700	1		_aHan, Junfeng
700	1		_aWang, Huiming
700	1		_aWu, Yuzhang
773	0		_tCancer immunology, immunotherapy : CII _gvol. 56 _gno. 3 _gp. 319-29
856	4	0	_uhttps://doi.org/10.1007/s00262-006-0195-x _zAvailable from publisher's website
999			_c16493766 _d16493766